Skip to content

Clinical trials

Recruiting Precursor Cell Lymphoblastic Leukemia-Lymphoma trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Precursor Cell Lymphoblastic Leukemia-Lymphoma Status: Recruiting Country / region: China Clear all

70 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20181
20191
20205
20227
20233
202425
202524
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting70

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Institute of Hematology & Blood Diseases Hospital, China12
Beijing GoBroad Hospital6
First Affiliated Hospital of Zhejiang University4
The First Affiliated Hospital of Zhengzhou University4
The First Affiliated Hospital of Soochow University3
Zhejiang University3
Chinese PLA General Hospital2
Nanfang Hospital, Southern Medical University2
Peking University People's Hospital2
PersonGen BioTherapeutics (Suzhou) Co., Ltd.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Precursor Cell Lymphoblastic Leukemia-Lymphoma70
Lymphoma, Non-Hodgkin10
Burkitt Lymphoma8
Leukemia, Myeloid, Acute6
Multiple Myeloma5
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma5
Recurrence5
Lymphoma, B-Cell4
Lymphoma3
Myelodysplastic Syndromes3

Trials

Showing 1 to 25 of 70. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.